New cardiovascular biomarkers in patients with advanced cancer – A prospective study comparing MR‐proADM, MR‐proANP, copeptin, high‐sensitivity troponin T and NT‐proBNP.

Saved in:
Bibliographic Details
Title: New cardiovascular biomarkers in patients with advanced cancer – A prospective study comparing MR‐proADM, MR‐proANP, copeptin, high‐sensitivity troponin T and NT‐proBNP.
Authors: Anker, Markus S.1,2,3,4 (AUTHOR) markus.anker@charite.de, Lück, Laura C.1,2,3,5 (AUTHOR), Khan, Muhammad Shahzeb6 (AUTHOR), Porthun, Jan1,5,7 (AUTHOR), Hadzibegovic, Sara1,2,3,4 (AUTHOR), Lena, Alessia1,2,3,4 (AUTHOR), Wilkenshoff, Ursula1,4 (AUTHOR), Weinländer, Pia1,2,3,5 (AUTHOR), Evertz, Ruben8,9 (AUTHOR), Totzeck, Matthias10 (AUTHOR), Mahabadi, Amir A.10 (AUTHOR), Rassaf, Tienush10 (AUTHOR), Anker, Stefan D.2,3,11 (AUTHOR), Bullinger, Lars12,13 (AUTHOR), Keller, Ulrich12,14,15 (AUTHOR), Karakas, Mahir16,17 (AUTHOR), Landmesser, Ulf1,2,4,18 (AUTHOR), Butler, Javed19,20 (AUTHOR), von Haehling, Stephan8,9 (AUTHOR)
Source: European Journal of Heart Failure. Jun2025, Vol. 27 Issue 6, p1047-1055. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13889842
DOI:10.1002/ejhf.3497